Naturally Occurring Alpha-Synuclein Autoantibodies in Parkinson’s Disease: Sources of (Error) Variance in Biomarker Assays
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Naturally Occurring Alpha-Synuclein Autoantibodies in Parkinson’s Disease: Sources of (Error) Variance in Biomarker Assays
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 12, Pages e114566
Publisher
Public Library of Science (PLoS)
Online
2014-12-04
DOI
10.1371/journal.pone.0114566
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models
- (2014) D. Games et al. JOURNAL OF NEUROSCIENCE
- Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease
- (2014) Daniela Berg et al. MOVEMENT DISORDERS
- Comparable Autoantibody Serum Levels against Amyloid- and Inflammation-Associated Proteins in Parkinson’s Disease Patients and Controls
- (2014) Walter Maetzler et al. PLoS One
- Parkinson Disease Subtypes
- (2014) Mary Ann Thenganatt et al. JAMA Neurology
- Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons
- (2013) Jing L. Guo et al. CELL
- Mechanisms of action of naturally occurring antibodies against β-amyloid on microglia
- (2013) Maike Gold et al. Journal of Neuroinflammation
- Prion Peptide Uptake in Microglial Cells – The Effect of Naturally Occurring Autoantibodies against Prion Protein
- (2013) Yvonne Roettger et al. PLoS One
- Altered Serum IgG Levels to α-Synuclein in Dementia with Lewy Bodies and Alzheimer’s Disease
- (2013) Niklas K. U. Koehler et al. PLoS One
- Elevated Alpha-Synuclein Impairs Innate Immune Cell Function and Provides a Potential Peripheral Biomarker for Parkinson's Disease
- (2013) Shyra J. Gardai et al. PLoS One
- The remarkable conformational plasticity of alpha-synuclein: blessing or curse?
- (2013) Angélique Deleersnijder et al. TRENDS IN MOLECULAR MEDICINE
- Human Anti-prion Antibodies Block Prion Peptide Fibril Formation and Neurotoxicity
- (2012) Xing Wei et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, andEscherichia coliExists Predominantly as Disordered Monomer
- (2012) Bruno Fauvet et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Elevated Levels of α-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Naïve Patients with Parkinson's Disease
- (2012) Min Jeong Park et al. Journal of Clinical Neurology
- Antibody-Aided Clearance of Extracellular -Synuclein Prevents Cell-to-Cell Aggregate Transmission
- (2012) E.-J. Bae et al. JOURNAL OF NEUROSCIENCE
- Correlation between Protective Immunity to a-Synuclein Aggregates, Oxidative Stress and Inflammation
- (2012) Marina A. Gruden et al. NEUROIMMUNOMODULATION
- Naturally occurring -synuclein autoantibody levels are lower in patients with Parkinson disease
- (2012) D. Besong-Agbo et al. NEUROLOGY
- α-Synuclein and Anti-α-Synuclein Antibodies in Parkinson’s Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls
- (2012) Lynnae M. Smith et al. PLoS One
- Pathogenic protein seeding in alzheimer disease and other neurodegenerative disorders
- (2011) Mathias Jucker et al. ANNALS OF NEUROLOGY
- Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease
- (2011) Penelope G. Foulds et al. FASEB JOURNAL
- Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression
- (2011) Marina A. Gruden et al. JOURNAL OF NEUROIMMUNOLOGY
- Naturally Occurring Autoantibodies against -Amyloid: Investigating Their Role in Transgenic Animal and In Vitro Models of Alzheimer's Disease
- (2011) R. Dodel et al. JOURNAL OF NEUROSCIENCE
- α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
- (2011) Brit Mollenhauer et al. LANCET NEUROLOGY
- DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
- (2010) Zhen Hong et al. BRAIN
- Plasma α-synuclein in patients with Parkinson's disease with and without treatment
- (2010) Raquel Duran et al. MOVEMENT DISORDERS
- Detection of elevated levels of -synuclein oligomers in CSF from patients with Parkinson disease
- (2010) T. Tokuda et al. NEUROLOGY
- Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease
- (2010) Min Shi et al. NEUROSCIENCE LETTERS
- Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
- (2008) Brit Mollenhauer et al. EXPERIMENTAL NEUROLOGY
- Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
- (2008) Jia-Yi Li et al. NATURE MEDICINE
- Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood
- (2008) Robin Barbour et al. Neurodegenerative Diseases
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started